ctrl K

Price Alert

Regencell Bioscience Lim... (RGC)

NASDAQ: RGC · Real-Time Price · USD

12.80

0.10 (0.79%)

At close: Aug 15, 2025, 12:16 PM

Regencell Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2.96M	1.56M	6.42M	59.41K
Short-Term Investments	5M	10M	10M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	97.68K	108.5K	114.3K	191.42K
Receivables	152.78K	56.55K	n/a	n/a
Inventory	n/a	-56.55K	-27.6K	-7.44K
Other Current Assets	n/a	n/a	0.00	n/a
Total Current Assets	8.11M	11.62M	16.44M	66.85K
Property-Plant & Equipment	226.51K	891.91K	1.46M	81.86K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	324.2K	1M	1.57M	273.29K
Total Assets	8.44M	12.62M	18.02M	340.13K
Account Payables	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	3.68M
Other Current Liabilities	n/a	n/a	n/a	n/a
Total Current Liabilities	193.58K	606.91K	577.76K	4.34M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	25.93K	25.41K	360.27K	n/a
Total Liabilities	219.51K	632.32K	938.03K	4.34M
Total Debt	85.74K	463.67K	771.25K	3.68M
Common Stock	130.00	130.00	130.00	100.00
Retained Earnings	-21.62M	-17.32M	-11.44M	-4M
Comprehensive Income	-45.77K	-86.66K	0.00	n/a
Shareholders Equity	8.22M	12.03M	17.07M	-4M
Total Investments	5M	10M	10M	n/a